We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$33B
AUM Growth
+$5.76B
Cap. Flow
+$4.83B
Cap. Flow %
14.64%
Top 10 Hldgs %
18%
Holding
1,503
New
268
Increased
383
Reduced
361
Closed
471

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$470M
2
AMZN icon
Amazon
AMZN
+$436M
3
GE icon
GE Aerospace
GE
+$381M
4
RY icon
Royal Bank of Canada
RY
+$368M
5
CNI icon
Canadian National Railway
CNI
+$354M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$365M
2
CSCO icon
Cisco
CSCO
+$266M
3
GSK icon
GSK
GSK
+$248M
4
CVS icon
CVS Health
CVS
+$187M
5
BTI icon
British American Tobacco
BTI
+$168M

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Financials 19.11%
3 Healthcare 13.53%
4 Consumer Staples 11.65%
5 Industrials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECOM
976
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$240K ﹤0.01%
20,816
-17,000
-45% -$197K
AWRE icon
977
Aware
AWRE
$26M
$238K ﹤0.01%
46,302
CADE
978
DELISTED
Cadence Bank
CADE
$238K ﹤0.01%
+7,800
New +$234K
ORAN
979
DELISTED
Orange
ORAN
$237K ﹤0.01%
+14,800
New +$241K
NSH
980
DELISTED
NuStar GP Holdings LLC
NSH
$237K ﹤0.01%
+9,700
New +$251K
BCC icon
981
Boise Cascade
BCC
$2.69B
$234K ﹤0.01%
+7,693
New +$224K
ALT icon
982
Altimmune
ALT
$552M
$231K ﹤0.01%
2,411
+235
+11% +$39.1K
VATE icon
983
INNOVATE Corp
VATE
$111M
$231K ﹤0.01%
3,932
+2,372
+152% +$136K
HQY icon
984
HealthEquity
HQY
$8.41B
$224K ﹤0.01%
+4,500
New +$210K
BP icon
985
BP
BP
$116B
$222K ﹤0.01%
7,219
-36,321
-83% -$1.13M
MITT
986
TPG Mortgage Investment Trust
MITT
$222M
$220K ﹤0.01%
+4,000
New +$223K
EGIO
987
DELISTED
Edgio, Inc. Common Stock
EGIO
$220K ﹤0.01%
+1,900
New +$221K
ARAV
988
DELISTED
Aravive, Inc. Common Stock
ARAV
$216K ﹤0.01%
2,067
-3,493
-63% -$375K
LKFT
989
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$214K ﹤0.01%
+2,800
New +$236K
TZOO icon
990
Travelzoo
TZOO
$74.3M
$212K ﹤0.01%
19,355
CALL
991
DELISTED
magicJack VocalTec Ltd
CALL
$211K ﹤0.01%
29,300
-1,900
-6% -$14.5K
NEWT icon
992
NewtekOne
NEWT
$428M
$207K ﹤0.01%
+12,710
New +$213K
LYG icon
993
Lloyds Banking Group
LYG
$89.5B
$205K ﹤0.01%
58,200
-559,000
-91% -$1.99M
CHCT
994
Community Healthcare Trust
CHCT
$523M
$204K ﹤0.01%
+7,973
New +$200K
CLB icon
995
Core Laboratories
CLB
$488M
$203K ﹤0.01%
+2,000
New +$216K
CHTR icon
996
Charter Communications
CHTR
$17.3B
$202K ﹤0.01%
600
-500
-45% -$167K
LE icon
997
Lands' End
LE
$370M
$199K ﹤0.01%
+13,340
New +$254K
OOMA icon
998
Ooma
OOMA
$598M
$195K ﹤0.01%
+24,378
New +$249K
TI
999
DELISTED
Telecom Italia
TI
$194K ﹤0.01%
+20,700
New +$192K
NMM icon
1000
Navios Maritime Partners
NMM
$2.3B
$188K ﹤0.01%
+7,887
New +$212K

Similar funds

Arrowstreet Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Arrowstreet Capital held 1,503 positions worth $33B, up 21% from $27.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Arrowstreet Capital deployed $4.83B of net new capital in Q2 2017, opening 268 new positions and adding to 383 existing holdings. Its largest new stake was MetLife: 1,568,893 shares worth $76.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cisco, an estimated $266M trimmed.

  • Arrowstreet Capital's largest Q2 2017 buy was MetLife: 1,568,893 shares worth $76.8M.
  • Arrowstreet Capital added most to Apple in Q2 2017, an estimated $470M increase.
  • Arrowstreet Capital's biggest Q2 2017 reduction was Cisco, cutting an estimated $266M.
  • Arrowstreet Capital fully exited AT&T in Q2 2017, selling an estimated $365M.
  • Arrowstreet Capital's ten largest holdings make up 18% of its $33B portfolio in Q2 2017.
  • Arrowstreet Capital opened 268 new positions and closed 471 in Q2 2017.
  • Arrowstreet Capital's portfolio value rose 21% quarter-over-quarter to $33B.

Based on Arrowstreet Capital's 13F filing for Q2 2017, filed 15 Aug 2017.